🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PALO-10-01 is a clinical study assessing efficacy and safety of a single or...
Status
Completed
Location
Genesis Cancer Centre
Start Date
2011-07
Trial ID
NCT01363479
Treatments Being Tested
RATIONALE: Fosaprepitant dimeglumine, palonosetron hydrochloride, and dexam...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2009-02
Trial ID
NCT00895245
This randomized phase III trial is studying APF530 and dexamethasone to see...
Status
Completed
Location
Anniston Oncology, PC
Start Date
2006-06
Trial ID
NCT00343460
Treatments Being Tested
Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Status
Completed
Location
Fifth Affilliated Hospital of Sun Yat-sen University
Start Date
2020-02-03
Trial ID
NCT04437017
Treatments Being Tested
The purpose of this study is to determine how automated recommendations are...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2016-07
Trial ID
NCT02625181
Treatments Being Tested
This prospective, multicenter, non-comparative, open-label trial design aim...
Status
Recruiting
Location
Shanghai Sixth People's Hospital
Start Date
2026-03-10
Trial ID
NCT07482891
Treatments Being Tested
Title of the study Aprepitant for prevention of acute and delayed nausea an...
Status
Unknown
Location
Azienda Ospedaliera di Perugia - Hematology dept.
Start Date
2010-04
Trial ID
NCT01088022
Treatments Being Tested
Postoperative nausea and vomiting (PONV) is defined as nausea and/or vomiti...
Status
Completed
Location
Mohd Zulfakar Mazlan, MBBS
Start Date
2020-07-06
Trial ID
NCT04461093
Treatments Being Tested
The purpose of this study is to determine if a single intravenous (IV) dose...
Status
Completed
Location
Multiple Locations
Start Date
2006-10-10
Trial ID
NCT00687011
Treatments Being Tested
This randomized phase III trial studies how well olanzapine with or without...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-11-20
Trial ID
NCT03578081